Log In Sign up
The largest database of trusted experimental protocols

Rbm25

Manufactured by Abcam
Visit Supplier

Rbm25 is an RNA-binding protein that regulates gene expression by binding to and modulating the splicing of target mRNAs. It plays a role in various cellular processes, including cell cycle regulation and the DNA damage response.

Automatically generated - may contain errors

Lab products found in correlation

Synaptophysin, by Abcam (2 mentions) Psd95, by Cell Signaling Technology (2 mentions) Anti aβ42, by Merck Group (2 mentions) App c terminal, by Merck Group (2 mentions) H2 ab1, by Santa Cruz Biotechnology (2 mentions) β actin, by Cell Signaling Technology (2 mentions) γh2ax, by Fortis Life Sciences (1 mentions) Pchk1 s345, by Cell Signaling Technology (1 mentions) Eef1b2, by Proteintech (1 mentions) Vinculin, by Santa Cruz Biotechnology (1 mentions) Phospho smad2 ser465 ser467, by Cell Signaling Technology (1 mentions) Mgat4a, by Abcam (1 mentions) Myct1, by Abcam (1 mentions) P chk1 s317, by Cell Signaling Technology (1 mentions) Tgfbr2, by Cell Signaling Technology (1 mentions) Gapdh, by Santa Cruz Biotechnology (1 mentions)

3 protocols using rbm25

1

Antibody Panel for Neurodegenerative Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were purchased from Abcam: BHMT (#ab96415), CD68 (#ab955), Rbm25 (#ab72237), Synaptophysin (#ab32127). Cell signaling: β-actin (#4967), Pin1 (#3722), PSD95 (#3409). Millipore: anti-Aβ42 (#5078P), 6E10 (#MAB1560), APP C-terminal (#171610). Santa Cruz Biotechnology: H2-Ab1 (#sc-71201). Wako: Iba1 (NCNP24).
Velazquez R., Ferreira E., Winslow W., Dave N., Piras I.S., Naymik M., Huentelman M.J., Tran A., Caccamo A, & Oddo S. (2019). Maternal choline supplementation ameliorates Alzheimer’s disease pathology by reducing brain homocysteine levels across multiple generations. Molecular psychiatry, 25(10), 2620-2629.
+ Open protocol
+ Expand
2

Antibody-based Protein Detection Workflow

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell extracts and western blots were performed as previously described [55 (link)]. Antibodies used were: MED12 (Santa Cruz Biotechnology sc-515695), SOD2 (Santa Cruz Biotechnology sc-133254), LUC7L3 (ProteinTech 145041AP), EEF1B2 (ProteinTech 104831AP), BCL-Xshort (Invitrogen PA5-78864), Vinculin (Santa Cruz Biotechnology sc-73614), GAPDH (Santa Cruz Biotechnology sc-47724), Cas9 (BioLegend 844302), pChk1-S317(Cell Signaling Technology 2344S), pChk1-S345(Cell Signaling 2341S), IRF2BP2 (ProteinTech 188471AP), RPL35A (Bethyl, 501569555), MED7 (Abcam ab187146), MED13 (Invitrogen PA5-35924), CCNC (Bethyl A301-989A-T), CDK8 (ProteinTech 220671AP), TGFBR2 (Cell Signaling Technology 79424S), RNASEH2 (Bethyl A304-149A-T), RBM25 (Abcam ab72237), γH2AX (Bethyl A300-081A), phospho-SMAD2 Ser465/Ser467 (Cell Signaling Technology 18338T), MGAT4A (Abcam ab151750), MYCT1 (Abcam ab139945), BCL-Xlong, (Santa Cruz Biotechnology sc-271121), RETSAT (invitrogen PA5-65443), KNTC1 (Bethyl A301-712A-T), LIAS (Abcam ab96302).
Schleicher E.M., Dhoonmoon A., Jackson L.M., Clements K.E., Stump C.L., Nicolae C.M, & Moldovan G.L. (2020). Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors. PLoS Genetics, 16(11), e1009176.
+ Open protocol
+ Expand
3

Antibody Panel for Neurodegenerative Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were purchased from Abcam: BHMT (#ab96415), CD68 (#ab955), Rbm25 (#ab72237), Synaptophysin (#ab32127). Cell signaling: β-actin (#4967), Pin1 (#3722), PSD95 (#3409). Millipore: anti-Aβ42 (#5078P), 6E10 (#MAB1560), APP C-terminal (#171610). Santa Cruz Biotechnology: H2-Ab1 (#sc-71201). Wako: Iba1 (NCNP24).
Velazquez R., Ferreira E., Winslow W., Dave N., Piras I.S., Naymik M., Huentelman M.J., Tran A., Caccamo A, & Oddo S. (2019). Maternal choline supplementation ameliorates Alzheimer’s disease pathology by reducing brain homocysteine levels across multiple generations. Molecular psychiatry, 25(10), 2620-2629.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!